Research on the IgE, EOS, LTE-4 content and its clinical significance with the inacute phase of pediatric asthma
10.3969/j.issn.1005-1678.2017.02.094
- VernacularTitle:小儿哮喘非急性发作期IgE、EOS、LTE-4含量的变化及其临床意义
- Author:
Junfang GONG
;
Chunyan WANG
;
Jiaolei CHEN
- Keywords:
patients with pediatric asthma clinical symptoms of the inacute phase;
total serum immunoglobulin ( IgE );
peripheral blood eosinophils (EOS);
urinary leukotriene E4 (LTE-4)
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(2):300-301,304
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical significance of total serum immunoglobulin ( IgE) , peripheral blood eosinophils ( EOS) and urinary leukotriene E4 ( LTE-4 ) detection on pediatric asthma clinical symptoms of the inacute phase .Methods 90 cases with pediatric asthma clinical symptoms of the inacute phase from March 2014 to March 2015 were selected as experimental group, and divided into the general asthma group(n=32), the moderate asthma group(n=31), the sereval asthma group(n=27) and another 30 health children as control group.Give each patients children doses of β2 agonists (LABA) as monotherapy, and inhaled corticosteroids (ICS) used as combination therapy.The use of LABA is 3-4 times/d.After three months' treatment, clinical efficacy were evaluated, and IgE, EOS, LTE-4 content were detected.Results After 3 months' treatment, IgE, EOS, LTE-4 contents in three experiment groups were significantly decreased (P<0.05), improved to the basic condition compared to control groups.The clinical efficacy among three groups had no significant differences.Conclusion IgE, EOS, LTE-4 levels detection of patients with pediatric asthma clinical symptoms of the inacute phase had evaluation significance, can be a good indicator of pediatric asthma health recovery in patients of the inacute phase.
